{"id":"https://openalex.org/W2560190802","doi":"https://doi.org/10.1097/qai.0000000000001168","title":"Brief Report: Factors Associated With the Selection of Initial Antiretroviral Therapy From 2009 to 2012","display_name":"Brief Report: Factors Associated With the Selection of Initial Antiretroviral Therapy From 2009 to 2012","publication_year":2016,"publication_date":"2016-08-23","ids":{"openalex":"https://openalex.org/W2560190802","doi":"https://doi.org/10.1097/qai.0000000000001168","mag":"2560190802","pmid":"https://pubmed.ncbi.nlm.nih.gov/27552153","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5140679"},"language":"en","primary_location":{"id":"doi:10.1097/qai.0000000000001168","doi":"https://doi.org/10.1097/qai.0000000000001168","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0000000000001168","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5140679","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066136225","display_name":"Michael S. Saag","orcid":"https://orcid.org/0000-0002-8866-1043","observed_orcids":["https://orcid.org/0000-0002-8866-1043"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael S. Saag","raw_affiliation_strings":["Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052633473","display_name":"Andrew O. Westfall","orcid":"https://orcid.org/0000-0002-0468-4695","observed_orcids":["https://orcid.org/0000-0002-0468-4695"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew O. Westfall","raw_affiliation_strings":["Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101692794","display_name":"Stephen R. Cole","orcid":"https://orcid.org/0000-0003-2117-1311","observed_orcids":["https://orcid.org/0000-0003-2117-1311"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen R. Cole","raw_affiliation_strings":["Department of Epidemiology, University of North Carolina, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, University of North Carolina, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067905523","display_name":"William C. Mathews","orcid":"https://orcid.org/0000-0002-2352-0725","observed_orcids":["https://orcid.org/0000-0002-2352-0725"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William C. Mathews","raw_affiliation_strings":["Owen Clinic, University of California, San Diego, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Owen Clinic, University of California, San Diego, San Diego, CA;","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043139740","display_name":"Daniel R. Drozd","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel R. Drozd","raw_affiliation_strings":["Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA;","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025150770","display_name":"Kenneth Hugh Mayer","orcid":"https://orcid.org/0000-0001-7460-733X","observed_orcids":["https://orcid.org/0000-0001-7460-733X","https://orcid.org/0000-0001-8034-5110"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I44580034","display_name":"Fenway Health","ror":"https://ror.org/04ztdzs79","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I44580034"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth H. Mayer","raw_affiliation_strings":["Department of Medicine, Harvard Medical School, Boston, MA; and","Fenway Health Clinic, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Harvard Medical School, Boston, MA; and","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Fenway Health Clinic, Boston, MA;","institution_ids":["https://openalex.org/I44580034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021580400","display_name":"Greer Burkholder","orcid":"https://orcid.org/0000-0001-7185-3025","observed_orcids":["https://orcid.org/0000-0001-7185-3025"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Greer A. Burkholder","raw_affiliation_strings":["Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL;","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077239845","display_name":"Mari M. Kitahata","orcid":"https://orcid.org/0000-0002-5410-7175","observed_orcids":["https://orcid.org/0000-0002-5410-7175"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mari Kitahata","raw_affiliation_strings":["Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA;","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091357745","display_name":"Eric M. Maiese","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Eric M. Maiese","raw_affiliation_strings":["Merck Sharp & Dohme Corp., Kenilworth, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp & Dohme Corp., Kenilworth, NJ","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5021580400","https://openalex.org/A5066136225","https://openalex.org/A5091357745"],"corresponding_institution_ids":["https://openalex.org/I32389192"],"apc_list":null,"apc_paid":null,"fwci":0.9227,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.78918649,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"74","issue":"1","first_page":"60","last_page":"64"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9653000235557556,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.033399999141693115,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/initial-antiretroviral-therapy","display_name":"initial antiretroviral therapy","score":0.8320000171661377},{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.7310000061988831},{"id":"https://openalex.org/keywords/non-nucleoside-reverse-transcriptase-inhibitors","display_name":"non-nucleoside reverse transcriptase inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/boosted-protease-inhibitors","display_name":"boosted protease inhibitors","score":0.8870000243186951},{"id":"https://openalex.org/keywords/raltegravir","display_name":"raltegravir","score":0.9980000257492065},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.7059999704360962},{"id":"https://openalex.org/keywords/hepatitis-c-coinfection","display_name":"hepatitis C coinfection","score":0.8619999885559082},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.753000020980835},{"id":"https://openalex.org/keywords/liver-disease","display_name":"liver disease","score":0.9419999718666077},{"id":"https://openalex.org/keywords/substance-use","display_name":"substance use","score":0.921999990940094},{"id":"https://openalex.org/keywords/baseline-viral-load","display_name":"baseline viral load","score":0.8529999852180481}],"concepts":[{"id":"https://openalex.org/C2780404665","wikidata":"https://www.wikidata.org/wiki/Q421552","display_name":"Raltegravir","level":5,"score":0.9018656015396118},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.8074962496757507},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6648198366165161},{"id":"https://openalex.org/C2777302000","wikidata":"https://www.wikidata.org/wiki/Q412251","display_name":"Integrase inhibitor","level":5,"score":0.5888429284095764},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.5850824117660522},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5822815895080566},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5391687750816345},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.49613532423973083},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.48250293731689453},{"id":"https://openalex.org/C2777275308","wikidata":"https://www.wikidata.org/wiki/Q234668","display_name":"Cart","level":2,"score":0.41661351919174194},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.3969159424304962},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.33909907937049866},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.3360573649406433},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.31384676694869995},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1097/qai.0000000000001168","doi":"https://doi.org/10.1097/qai.0000000000001168","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0000000000001168","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},{"id":"pmid:27552153","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27552153","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of acquired immune deficiency syndromes (1999)","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5140679","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5140679","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Acquir Immune Defic Syndr","raw_type":"Text"},{"id":"pmh:cdr.lib.unc.edu:wd3762063","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.17615/p4d8-6m92","pdf_url":"https://doi.org/10.17615/p4d8-6m92","source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JAIDS - Journal of Acquired Immune Deficiency Syndromes, 74(1)","raw_type":"Article"},{"id":"doi:10.17615/p4d8-6m92","doi":"https://doi.org/10.17615/p4d8-6m92","is_oa":true,"landing_page_url":"https://doi.org/10.17615/p4d8-6m92","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:5140679","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5140679","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Acquir Immune Defic Syndr","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G1090173496","display_name":null,"funder_award_id":"AI027767","funder_id":"https://openalex.org/F4320334435","funder_display_name":"Center for AIDS Research, University of Alabama at Birmingham"},{"id":"https://openalex.org/G9000877288","display_name":"CFAR Network of Integrated Clinical Systems (CNICS)","funder_award_id":"R24AI067039","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000894295","display_name":"The University of North Carolina Center for AIDS Research","funder_award_id":"P30AI050410","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G9000921343","display_name":"UAB Center for AIDS Research (CFAR)","funder_award_id":"P30AI027767","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320334435","display_name":"Center for AIDS Research, University of Alabama at Birmingham","ror":null},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1908874736","https://openalex.org/W1994603066","https://openalex.org/W2019690398","https://openalex.org/W2021462937","https://openalex.org/W2030038632","https://openalex.org/W2032623485","https://openalex.org/W2036350240","https://openalex.org/W2044969536","https://openalex.org/W2068866500","https://openalex.org/W2072527802","https://openalex.org/W2072661867","https://openalex.org/W2102062612","https://openalex.org/W2103798805","https://openalex.org/W2130874133","https://openalex.org/W2139430929","https://openalex.org/W2148750104","https://openalex.org/W2149717057","https://openalex.org/W2332910040","https://openalex.org/W4240243247"],"related_works":["https://openalex.org/W2563736726","https://openalex.org/W2018864799","https://openalex.org/W1988985994","https://openalex.org/W2012176284","https://openalex.org/W2971007567","https://openalex.org/W2347116978","https://openalex.org/W2327361398","https://openalex.org/W6892265258","https://openalex.org/W2028783380","https://openalex.org/W3141437108"],"abstract_inverted_index":{"We":[0],"examined":[1],"factors":[2],"associated":[3],"with":[4,60,73,82,92,100],"selection":[5,135],"of":[6],"initial":[7,133],"antiretroviral":[8,16,45],"regimen":[9,117,134],"in":[10,112],"the":[11,113],"CNICS":[12],"cohort.":[13],"Patients":[14,59],"initiating":[15,44],"therapy":[17,148],"between":[18],"July":[19],"2009":[20],"and":[21,56,62,79,98,126],"December":[22],"2012":[23],"were":[24,64,85,103],"classified":[25],"as":[26,143],"receiving":[27],"a":[28,53,108],"nonnucleoside":[29],"reverse":[30],"transcriptase":[31],"inhibitor":[32,36],"(NNRTI)-,":[33],"boosted":[34,54,109],"protease":[35],"(PI)-,":[37],"or":[38],"raltegravir-based":[39],"regimen.":[40],"Among":[41],"873":[42],"patients":[43],"therapy,":[46],"488":[47],"regimens":[48],"contained":[49],"an":[50,69],"NNRTI,":[51,70],"319":[52],"PI,":[55],"66":[57],"raltegravir.":[58,90],"depression":[61],"women":[63],"less":[65],"likely":[66,87,105,137],"to":[67,88,106,120],"receive":[68,89,107],"whereas":[71],"those":[72,80,99],"underlying":[74],"cardiovascular":[75],"disease,":[76,78],"liver":[77],"coinfected":[81],"hepatitis":[83],"C":[84],"more":[86,104,139,144],"Those":[91],"baseline":[93,128],"viral":[94],"load":[95],">100,000":[96],"c/ml":[97],"substance":[101],"use":[102],"PI.":[110],"Thus,":[111],"\"real":[114],"world,\"":[115],"ARV":[116],"choices":[118,145],"appear":[119],"take":[121],"into":[122],"account":[123],"adverse":[124],"effects":[125],"patient":[127],"characteristics.":[129],"Factors":[130],"that":[131],"impact":[132],"will":[136],"become":[138,149],"heterogeneous":[140],"over":[141],"time":[142],"for":[146],"HIV":[147],"available.":[150]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-12-16T00:00:00"}